Formulations of pimavanserin | Patent Number 10849891

US 10849891 B2
Application Number16836086
Publication NumberUS 20200222381 A1
Pendency8 months, 5 days
Filled DateMar 31, 2020
Priority Date-
Publication DateJul 16, 2020
Expiration DateMar 30, 2040
Inventor/ApplicantsRavi Tejwani
Stephen Edward Abele
Emanuel Joseph Vizzotti
ExaminesYOUNG, MICAH PAUL
Art Unit1618
Technology Center1600
Assignments
Acadia Pharmaceuticals Inc.
Current
Acadia Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.